Filgotinib in Long-Term Extension Study of Adults With Ulcerative Colitis
NCT02914535
Original registry description
The primary objective of this study is to observe the long-term safety of filgotinib in adults who have completed or met protocol specified efficacy discontinuation criteria in a prior filgotinib treatment study in ulcerative colitis (UC).